Ultra-orphan diseases: A cross-sectional quantitative analysis of the natural history of isolated sulfite oxidase deficiency
PLOS One · 29.05.2025 · 20 (5) · e0323043
DOI: 10.1371/journal.pone.0323043 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS One, online erschienen am 29.05.2025. Verfasst von Laura Göde und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty Heidelberg, and Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, U…. Hauptthemen laut MEDLINE: Sulfite Oxidase, Amino Acid Metabolism, Inborn Errors, Rare Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Isolated sulfite oxidase deficiency (ISOD; OMIM #272300) is a devastating rare neurometabolic disorder due to biallelic pathogenic variants in the SUOX gene, that typically results in neonatal refractory epilepsy and progressive severe encephalopathy. Knowledge on the quantitative natural history of ISOD is limited and clinical outcome parameters for future clinical trials remain to be defined. Material and methods We performed a comprehensive analysis of published cases (N=74) with ISOD applying quantitative retrospective natural history modeling (QUARNAM). Main outcome parameters were age of disease onset, diagnostic delay and survival. Clinical characteristics and potential associations between biochemical parameters and clinical outcome (i.e. age of disease onset, survival) were explored.
Results
The median survival period of the study cohort was 60 months. ISOD typically presented shortly after birth with a median age of onset of 3 days. Median age at diagnosis was 10 months, leading to a substantial median diagnostic delay of 5.7 months. Homocysteine concentrations in plasma correlated with age of disease onset. An association of biochemical parameters of cysteine metabolism and survival could not be identified.
Conclusion
The present analysis describes long-term outcome measures adding to the quantitative understanding of the natural history of ISOD, which might be helpful in the planning of prospective clinical trials and potentially stimulate development of targeted therapies in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Faculty Heidelberg, and Center for Pediatric and Adolescent Medicine, Department I, Division of Pediatric Neurology and Metabolic Medicine, University Hospital Heidelberg, Heidelberg University, Im Neuenheimer F…
ORCID-Profile: Matthias Zielonka
Zitieren
APA
Göde, L., Zielonka, M., Garbade, S. F., & Posset, R. (2025). Ultra-orphan diseases: A cross-sectional quantitative analysis of the natural history of isolated sulfite oxidase deficiency. PLOS One, 20(5), e0323043. https://doi.org/10.1371/journal.pone.0323043
Vancouver
Göde L, Zielonka M, Garbade SF, Posset R. Ultra-orphan diseases: A cross-sectional quantitative analysis of the natural history of isolated sulfite oxidase deficiency. PLOS One. 2025;20(5):e0323043. doi:10.1371/journal.pone.0323043
BibTeX
@article{Gde2025,
author = {Göde, Laura and Zielonka, Matthias and Garbade, Sven F and Posset, Roland},
title = {Ultra-orphan diseases: A cross-sectional quantitative analysis of the natural history of isolated sulfite oxidase deficiency},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {5},
pages = {e0323043},
doi = {10.1371/journal.pone.0323043}
}
EUVIMED